The need for fast-track, high-quality and low-cost studies about the role of the BCG vaccine in the fight against COVID-19
Autor(a) principal: | |
---|---|
Data de Publicação: | 2020 |
Outros Autores: | , , , , , , , , , , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Repositório Institucional da FIOCRUZ (ARCA) |
Texto Completo: | https://www.arca.fiocruz.br/handle/icict/42238 |
Resumo: | Federal University of Bahia. Institute of Collective Health. Salvador, BA, Brazil. |
id |
CRUZ_0cfc874e7b484a31691c4b79e2a8f6cd |
---|---|
oai_identifier_str |
oai:www.arca.fiocruz.br:icict/42238 |
network_acronym_str |
CRUZ |
network_name_str |
Repositório Institucional da FIOCRUZ (ARCA) |
repository_id_str |
2135 |
spelling |
Pereira, MarcosPaixão, EnnyTrajman, AneteSouza, Ramon Andrade deNatividade, Marcio Santos daPescarini, Julia M.Pereira, Susan MartinsBarreto, Florisneide RodriguesXimenes, RicardoDalcomo, MargarethIchihara, Maria YuryNunes, CeuciBarral Netto, ManoelBarreto, Maurício Lima2020-07-14T11:07:17Z2020-07-14T11:07:17Z2020PEREIRA, Marcos et al. The need for fast-track, high-quality and low-cost studies about the role of the BCG vaccine in the fight against COVID-19. Respiratory Research, v. 21, p. 1-3, 2020.1465-9921https://www.arca.fiocruz.br/handle/icict/4223810.1186/s12931-020-01439-4engBMCCOVID-19Vacina BCGSindrome respiratória agudaCoronavirusSARS-CoV-2Bacillus Calmette GuerinMortalidadeCOVID-19BCG VaccineAcute Respiratory SyndromeCoronavirusSARS-CoV-2Bacillus Calmette GuerinMortalityThe need for fast-track, high-quality and low-cost studies about the role of the BCG vaccine in the fight against COVID-19info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleFederal University of Bahia. Institute of Collective Health. Salvador, BA, Brazil.Fundação Oswaldo Cruz. Instituto Gonçalo Moniz. Centro de Integração de Dados e Conhecimento para Saúde. Salvador, BA, Brasil / London School of Hygiene and Tropical Medicine. Faculty of Epidemiology London, UK.Universidade do Estado do Rio de Janeiro. Instituto de Medicina Social. Rio de Janeiro, RJ, Brazil.Federal University of Bahia. Institute of Collective Health. Salvador, BA, Brazil.Federal University of Bahia. Institute of Collective Health. Salvador, BA, Brazil.Fundação Oswaldo Cruz. Instituto Gonçalo Moniz. Centro de Integração de Dados e Conhecimento para Saúde. Salvador, BA, Brasil.Federal University of Bahia. Institute of Collective Health. Salvador, BA, Brazil.Federal University of Bahia. Institute of Collective Health. Salvador, BA, Brazil.Universidade Federal de Pernambuco. Departamento de Medicina Tropical. Recife, PE, Brasil.Fundação Oswaldo Cruz. Escola Nacional de Saúde Pública Sergio Arouca. Centro de Referência Hélio Fraga. Rio de Janeiro, RJ, Brasil.Fundação Oswaldo Cruz. Instituto Gonçalo Moniz. Centro de Integração de Dados e Conhecimento para Saúde. Salvador, BA, Brasil.Secretaria Estadual de Saúde da Bahia. Hospital Couto Maia. Salvador, BA, Brasil.Fundação Oswaldo Cruz. Instituto Gonçalo Moniz. Salvador, BA, Brasil / Universidade Federal da Bahia. Faculdade de Medicina. Salvador, BA, Brasil.Federal University of Bahia. Institute of Collective Health. Salvador, BA, Brazil / Fundação Oswaldo Cruz. Instituto Gonçalo Moniz. Centro de Integração de Dados e Conhecimento para Saúde. Salvador, BA, Brasil.Bacillus Calmette-Guérin (BCG) vaccination is routine and near-universal in many low- and middle-income countries (LMIC). It has been suggested that BCG can have a protective effect on COVID-19 morbidity and mortality. This commentary discusses the limitations of the evidence around BCG and COVID-19. We argue that higher-quality evidence is necessary to understand the protective effect of the BCG vaccine from existing, secondary data, while we await results from clinical trials currently conducted in different settings.info:eu-repo/semantics/openAccessreponame:Repositório Institucional da FIOCRUZ (ARCA)instname:Fundação Oswaldo Cruz (FIOCRUZ)instacron:FIOCRUZLICENSElicense.txtlicense.txttext/plain; charset=utf-82991https://www.arca.fiocruz.br/bitstream/icict/42238/1/license.txt5a560609d32a3863062d77ff32785d58MD51ORIGINALPereira_Marcos_etal_IGM_2020_COVID-19.pdfPereira_Marcos_etal_IGM_2020_COVID-19.pdfapplication/pdf468005https://www.arca.fiocruz.br/bitstream/icict/42238/2/Pereira_Marcos_etal_IGM_2020_COVID-19.pdf753fe47d85956019a0190b3034dea079MD52TEXTPereira_Marcos_etal_IGM_2020_COVID-19.pdf.txtPereira_Marcos_etal_IGM_2020_COVID-19.pdf.txtExtracted texttext/plain13768https://www.arca.fiocruz.br/bitstream/icict/42238/3/Pereira_Marcos_etal_IGM_2020_COVID-19.pdf.txtfd13df59e511f584c806f86208751370MD53icict/422382023-03-15 14:34:23.466oai:www.arca.fiocruz.br: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ório InstitucionalPUBhttps://www.arca.fiocruz.br/oai/requestrepositorio.arca@fiocruz.bropendoar:21352023-03-15T17:34:23Repositório Institucional da FIOCRUZ (ARCA) - Fundação Oswaldo Cruz (FIOCRUZ)false |
dc.title.pt_BR.fl_str_mv |
The need for fast-track, high-quality and low-cost studies about the role of the BCG vaccine in the fight against COVID-19 |
title |
The need for fast-track, high-quality and low-cost studies about the role of the BCG vaccine in the fight against COVID-19 |
spellingShingle |
The need for fast-track, high-quality and low-cost studies about the role of the BCG vaccine in the fight against COVID-19 Pereira, Marcos COVID-19 Vacina BCG Sindrome respiratória aguda Coronavirus SARS-CoV-2 Bacillus Calmette Guerin Mortalidade COVID-19 BCG Vaccine Acute Respiratory Syndrome Coronavirus SARS-CoV-2 Bacillus Calmette Guerin Mortality |
title_short |
The need for fast-track, high-quality and low-cost studies about the role of the BCG vaccine in the fight against COVID-19 |
title_full |
The need for fast-track, high-quality and low-cost studies about the role of the BCG vaccine in the fight against COVID-19 |
title_fullStr |
The need for fast-track, high-quality and low-cost studies about the role of the BCG vaccine in the fight against COVID-19 |
title_full_unstemmed |
The need for fast-track, high-quality and low-cost studies about the role of the BCG vaccine in the fight against COVID-19 |
title_sort |
The need for fast-track, high-quality and low-cost studies about the role of the BCG vaccine in the fight against COVID-19 |
author |
Pereira, Marcos |
author_facet |
Pereira, Marcos Paixão, Enny Trajman, Anete Souza, Ramon Andrade de Natividade, Marcio Santos da Pescarini, Julia M. Pereira, Susan Martins Barreto, Florisneide Rodrigues Ximenes, Ricardo Dalcomo, Margareth Ichihara, Maria Yury Nunes, Ceuci Barral Netto, Manoel Barreto, Maurício Lima |
author_role |
author |
author2 |
Paixão, Enny Trajman, Anete Souza, Ramon Andrade de Natividade, Marcio Santos da Pescarini, Julia M. Pereira, Susan Martins Barreto, Florisneide Rodrigues Ximenes, Ricardo Dalcomo, Margareth Ichihara, Maria Yury Nunes, Ceuci Barral Netto, Manoel Barreto, Maurício Lima |
author2_role |
author author author author author author author author author author author author author |
dc.contributor.author.fl_str_mv |
Pereira, Marcos Paixão, Enny Trajman, Anete Souza, Ramon Andrade de Natividade, Marcio Santos da Pescarini, Julia M. Pereira, Susan Martins Barreto, Florisneide Rodrigues Ximenes, Ricardo Dalcomo, Margareth Ichihara, Maria Yury Nunes, Ceuci Barral Netto, Manoel Barreto, Maurício Lima |
dc.subject.other.pt_BR.fl_str_mv |
COVID-19 Vacina BCG Sindrome respiratória aguda Coronavirus SARS-CoV-2 Bacillus Calmette Guerin Mortalidade |
topic |
COVID-19 Vacina BCG Sindrome respiratória aguda Coronavirus SARS-CoV-2 Bacillus Calmette Guerin Mortalidade COVID-19 BCG Vaccine Acute Respiratory Syndrome Coronavirus SARS-CoV-2 Bacillus Calmette Guerin Mortality |
dc.subject.en.pt_BR.fl_str_mv |
COVID-19 BCG Vaccine Acute Respiratory Syndrome Coronavirus SARS-CoV-2 Bacillus Calmette Guerin Mortality |
description |
Federal University of Bahia. Institute of Collective Health. Salvador, BA, Brazil. |
publishDate |
2020 |
dc.date.accessioned.fl_str_mv |
2020-07-14T11:07:17Z |
dc.date.available.fl_str_mv |
2020-07-14T11:07:17Z |
dc.date.issued.fl_str_mv |
2020 |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
format |
article |
status_str |
publishedVersion |
dc.identifier.citation.fl_str_mv |
PEREIRA, Marcos et al. The need for fast-track, high-quality and low-cost studies about the role of the BCG vaccine in the fight against COVID-19. Respiratory Research, v. 21, p. 1-3, 2020. |
dc.identifier.uri.fl_str_mv |
https://www.arca.fiocruz.br/handle/icict/42238 |
dc.identifier.issn.pt_BR.fl_str_mv |
1465-9921 |
dc.identifier.doi.none.fl_str_mv |
10.1186/s12931-020-01439-4 |
identifier_str_mv |
PEREIRA, Marcos et al. The need for fast-track, high-quality and low-cost studies about the role of the BCG vaccine in the fight against COVID-19. Respiratory Research, v. 21, p. 1-3, 2020. 1465-9921 10.1186/s12931-020-01439-4 |
url |
https://www.arca.fiocruz.br/handle/icict/42238 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.publisher.none.fl_str_mv |
BMC |
publisher.none.fl_str_mv |
BMC |
dc.source.none.fl_str_mv |
reponame:Repositório Institucional da FIOCRUZ (ARCA) instname:Fundação Oswaldo Cruz (FIOCRUZ) instacron:FIOCRUZ |
instname_str |
Fundação Oswaldo Cruz (FIOCRUZ) |
instacron_str |
FIOCRUZ |
institution |
FIOCRUZ |
reponame_str |
Repositório Institucional da FIOCRUZ (ARCA) |
collection |
Repositório Institucional da FIOCRUZ (ARCA) |
bitstream.url.fl_str_mv |
https://www.arca.fiocruz.br/bitstream/icict/42238/1/license.txt https://www.arca.fiocruz.br/bitstream/icict/42238/2/Pereira_Marcos_etal_IGM_2020_COVID-19.pdf https://www.arca.fiocruz.br/bitstream/icict/42238/3/Pereira_Marcos_etal_IGM_2020_COVID-19.pdf.txt |
bitstream.checksum.fl_str_mv |
5a560609d32a3863062d77ff32785d58 753fe47d85956019a0190b3034dea079 fd13df59e511f584c806f86208751370 |
bitstream.checksumAlgorithm.fl_str_mv |
MD5 MD5 MD5 |
repository.name.fl_str_mv |
Repositório Institucional da FIOCRUZ (ARCA) - Fundação Oswaldo Cruz (FIOCRUZ) |
repository.mail.fl_str_mv |
repositorio.arca@fiocruz.br |
_version_ |
1813009122234204160 |